Table 1. Summary of the primers used in the present study.

Primers	Sequences	Product size
EBNA1-Forward	5′AGGGTTAAGATATAGAGATGGTGTT 3′	129 bp
EBNA1-Reverse	5′ TACTCCTACCCCTCCTACTCCTAC 3′
U-LMP1-Forward	5′ TGGTTATGTTAGAGTAATGTG 3′	149 bp
U-LMP1-Reverse	5′ TTTCTACTTCCCCTTTCTATC 3′
M-RASSF1A- Forward	5′GTTTTGCGAGAGCGCG 3′	169 bp
M-RASSF1A- Reverse	5′ GGTAACAAACGCGAACG3′
ß-ACTIN -Forward	5′ AAGTTAAGTTTTGTTTTTATTTTT3′	184 bp
ß-ACTIN -Reverse	5′ CAATAATCTCCTTCTACATCCTATC3′
M-DAPK-Forward	5′ CGGTAGGGTTTGGGGTCG 3′	227 bp
M-DAPK-Reverse	5′ AAACCTCCCAACTTCGATCG 3′